Deyue Yan

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Reactive Oxygen Species

Tyrosine Kinase

Top Venues

Organic letters

ACS applied materials & interfaces

Science advances

Biomacromolecules

This page only lists publications with an associated author ORCID identifier.

Publications

Fei Li, Yicong Luo, Jinbao Ren, Qianjia Yuan, Deyue Yan, Wanbin Zhang
Iridium-Catalyzed Asymmetric Hydroarylation of Unactivated Alkenes with Heterobiaryls: Simultaneous Construction of Axial and Central Chirality. Organic letters 26 (32) (2024)
Qingrong Li, Xiaoyuan Yang, Xuelin Xia, Xiao-Xia Xia, Deyue Yan
Affibody-Functionalized Elastin-like Peptide-Drug Conjugate Nanomicelle for Targeted Ovarian Cancer Therapy. Biomacromolecules (2024)
Fei Li, Yicong Luo, Jinbao Ren, Qianjia Yuan, Deyue Yan, Wanbin Zhang
Iridium-Catalyzed Asymmetric Hydroarylation of Unactivated Alkenes with Heterobiaryls: Simultaneous Construction of Axial and Central Chirality. Organic letters (2024)
Fei Li, Jinbao Ren, Yifan Song, Qianjia Yuan, Deyue Yan, Wanbin Zhang
Iridium-Catalyzed 1,3-Rearrangement of Allylic Ethers. Organic letters (2023)
Tianbao Chen, Yuling Wang, Lijuan Zhu, Jingchun Wu, Jintang Lin, Wei Huang, Deyue Yan
Hybrid Membrane Camouflaged Chemodrug-Gene Nanoparticles for Enhanced Combination Therapy of Ovarian Cancer. ACS applied materials & interfaces (2023)
Jing Yuan, Zhanxiong Liu, Yachun Dong, Feng Gao, Xuelin Xia, Penghui Wang, Yanli Luo, Zhenfeng Zhang, Deyue Yan, Wanbin Zhang
Pioneering 4,11-Dioxo-4,11-dihydro-1 H -anthra[2,3- d ]imidazol-3-ium Compounds as Promising Survivin Inhibitors by Targeting ILF3/NF110 for Cancer Therapy. Journal of medicinal chemistry (2023)
Lu Meng, Fengmin Yang, Yan Pang, Zhenping Cao, Feng Wu, Deyue Yan, Jinyao Liu
Nanocapping-enabled charge reversal generates cell-enterable endosomal-escapable bacteriophages for intracellular pathogen inhibition. Science advances 8 (28) (2022)
Xiaoyuan Yang, Xuelin Xia, Xiao-Xia Xia, Zhao Sun, Deyue Yan
Improving Targeted Delivery and Antitumor Efficacy with Engineered Tumor Necrosis Factor-Related Apoptosis Ligand-Affibody Fusion Protein. Molecular pharmaceutics 18 (10) (2021)
Xuelin Xia, Xiaoyuan Yang, Ping Huang, Deyue Yan
ROS-Responsive Nanoparticles Formed from RGD-Epothilone B Conjugate for Targeted Cancer Therapy. ACS applied materials & interfaces 12 (16) (2020)